We are live on ! Find out more
BBHC

Brown Brothers Harriman & Co Portfolio holdings

AUM $18.6B
1-Year Est. Return 15.81%
This Fund
S&P 500
This Quarter Est. Return
+9.89%
1 Year Est. Return
+15.81%
3 Year Est. Return
+66.02%
5 Year Est. Return
+80.97%
10 Year Est. Return
+273.41%
AUM
$13B
AUM Growth
+$990M
Cap. Flow
-$56.8M
Cap. Flow %
-0.44%
Top 10 Hldgs %
41.73%
Holding
1,291
New
142
Increased
249
Reduced
362
Closed
132

Top Sells

Rank Stock Value
1
TDG icon
TransDigm Group
TDG
+$57.5M
2
GGG icon
Graco
GGG
+$29.8M
3
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$17.3M
4
MSFT icon
Microsoft
MSFT
+$15M
5
AOS icon
A.O. Smith
AOS
+$14.6M

Sector Composition

Rank Sector Weight
1 Financials 21.64%
2 Technology 20.9%
3 Healthcare 14%
4 Industrials 10.38%
5 Consumer Discretionary 8.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PHM icon
351
Pultegroup
PHM
$25.2B
$520K ﹤0.01%
4,310
TT icon
352
Trane Technologies
TT
$106B
$519K ﹤0.01%
1,730
-73
-4% -$19.8K
CDNS icon
353
Cadence Design Systems
CDNS
$90.2B
$515K ﹤0.01%
1,656
PTNQ icon
354
Pacer Trendpilot 100 ETF
PTNQ
$1.25B
$503K ﹤0.01%
7,328
VOT icon
355
Vanguard Morningstar Mid-Cap Growth ETF
VOT
$19.8B
$494K ﹤0.01%
2,093
PSX icon
356
Phillips 66
PSX
$89.5B
$493K ﹤0.01%
3,017
+75
+3% +$10.8K
VRSK icon
357
Verisk Analytics
VRSK
$23.6B
$493K ﹤0.01%
2,090
-75
-3% -$18K
NTAP icon
358
NetApp
NTAP
$38.9B
$488K ﹤0.01%
4,651
+528
+13% +$48.9K
EFX icon
359
Equifax
EFX
$21.4B
$484K ﹤0.01%
1,808
-30
-2% -$7.63K
REGN icon
360
Regeneron Pharmaceuticals
REGN
$82.1B
$483K ﹤0.01%
502
-189
-27% -$180K
WLY icon
361
John Wiley & Sons Class A
WLY
$2.52B
$477K ﹤0.01%
12,500
ONTO icon
362
Onto Innovation
ONTO
$15.7B
$474K ﹤0.01%
2,620
+4
+0.2% +$676
K
363
DELISTED
Kellanova
K
$474K ﹤0.01%
8,275
ELV icon
364
Elevance Health
ELV
$84.7B
$473K ﹤0.01%
912
-147
-14% -$73.1K
AEP icon
365
American Electric Power
AEP
$67.3B
$469K ﹤0.01%
5,448
+250
+5% +$20.3K
WSM icon
366
Williams-Sonoma
WSM
$29.5B
$469K ﹤0.01%
2,954
AGG icon
367
iShares Core US Aggregate Bond ETF
AGG
$137B
$467K ﹤0.01%
+4,771
New +$467K
XBI icon
368
State Street SPDR S&P Biotech ETF
XBI
$10.4B
$465K ﹤0.01%
4,905
MET icon
369
MetLife
MET
$61.5B
$462K ﹤0.01%
6,229
+604
+11% +$42.1K
CHRW icon
370
C.H. Robinson
CHRW
$17B
$459K ﹤0.01%
6,030
LSXMK
371
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
$458K ﹤0.01%
15,424
ET icon
372
Energy Transfer Partners
ET
$71.6B
$455K ﹤0.01%
28,895
+141
+0.5% +$2.05K
ENB icon
373
Enbridge
ENB
$113B
$453K ﹤0.01%
12,517
-13,654
-52% -$484K
TFX icon
374
Teleflex
TFX
$5.91B
$451K ﹤0.01%
1,994
-118
-6% -$28K
IP icon
375
International Paper
IP
$22.1B
$450K ﹤0.01%
11,523
+473
+4% +$17.2K

Similar funds

Brown Brothers Harriman & Co's Q1 2024 Portfolio in Review

As of Q1 2024, Brown Brothers Harriman & Co held 1,291 positions worth $13B, up 8.2% from $12B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Brown Brothers Harriman & Co's Q1 2024 filing shows 142 new, 249 increased, 362 reduced and 132 closed positions. Its largest new stake was Information Services Group: 273,116 shares worth $1.1M. The largest sale was TransDigm Group, an estimated $57.5M.

By sector, the portfolio is most concentrated in Financials at 22% of assets, up from 21% a quarter earlier, followed by Technology and Healthcare.

  • Brown Brothers Harriman & Co's largest Q1 2024 buy was Information Services Group: 273,116 shares worth $1.1M.
  • Brown Brothers Harriman & Co added most to Automatic Data Processing in Q1 2024, an estimated $82.1M increase.
  • Brown Brothers Harriman & Co's biggest Q1 2024 reduction was TransDigm Group, cutting an estimated $57.5M.
  • Brown Brothers Harriman & Co fully exited iShares ESG Aware MSCI EM ETF in Q1 2024, selling an estimated $1.03M.
  • Brown Brothers Harriman & Co's ten largest holdings make up 42% of its $13B portfolio in Q1 2024.
  • Brown Brothers Harriman & Co opened 142 new positions and closed 132 in Q1 2024.
  • Brown Brothers Harriman & Co's portfolio value rose 8.2% quarter-over-quarter to $13B.

Based on Brown Brothers Harriman & Co's 13F filing for Q1 2024, filed 10 May 2024.